• Newsroom»
  • Alerts»
  • CMS Aims to Clarify Medicare Policy on Clinical Trial...

Alert

Recommended Alerts

Sign Up For Alerts

Proposed Rule Seeks to Promote Adoption of Value-Based Purchasing Arrangements

On June 17, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that, if finalized, would modify significantly the current Medicaid Drug Rebate Program (MDRP) regulations, generally (but not entirely) directions long-favored by drug makers.

Read More

CMS Aims to Clarify Medicare Policy on Clinical Trial Coverage


Time to Read: 1 minutes Practices: Health Care, Life Sciences

Printer-Friendly Version

The Centers for Medicare & Medicaid Services has recently launched a number of initiatives addressing Medicare coverage of clinical trial services, including an upcoming "Question & Answer" document on coverage of clinical trial services; proposed revisions to the national coverage decision on clinical trial services; and a revised guidance document for certain national coverage decisions. To learn more about these significant CMS initiatives, click "Download PDF."

Printer-Friendly Version

Cookie Settings